With solid financial backing from parent company Alphabet, Inc., Google Ventures (GV) is pressing ahead with plans to invest heavily in medtech, biotech, and digital health ventures to disrupt and transform healthcare.
Venture capitalists pumped a record $57 billion into U.S. companies in 2014, but just 5.9 percent of those investments were in medtech companies, according to an industry report. In the first half of 2015, medtech companies have pulled in only 3.8 percent of venture dollars.
But while most investors have been hesitant to bet on healthcare companies, that’s not the case for GV, which has poured significant investments into companies in the medtech, life sciences, and digital health arenas, according to GV founder Bill Maris. He can afford to be bold, as GV’s funding draws from Alphabet’s huge financial resources.